Citrus greening disease (CGD), or Huanglongbing (HLB), is principal in Citrus farming because of its severe damage, decreased yield, poor quality of fruit, and frequent disappearance before harvest. Present research blended silver nanoparticles (AgNPs) colloid with chitooligomers and monomers (COAMs) to create the composites referred to as a “hybrid solution”. The hybrid solution has been synthesized for antimicrobial effects and plant growth stimulation. The hybrid solution was applied to cure the CGD, which was then tested using the results of the iodine test kit. Study results revealed that the mechanism for antibacterial properties is efficient and leads to cell death by silver ions (positive charge) attached to the cell wall of pathogens (negative charge). COAMs increase AgNPs’ ability to adhere to negatively charged bacterial cytoplasmic membranes and amplify their electrostatic interaction. There are synergistic antibacterial effects of AgNPs–COAMs. The findings reveal a notable increase in the shoot length of leaves which may be the reason for the growth stimulation function of the hybrid solution due to the properties of COAMs as a biostimulant. The hybrid solution-treated trees yielded around 104.50 ± 4.56 kg of fruits by the trunk or foliar application. Citrus fruits did not show the presence of any silver residues, as displayed by the results of the accumulation test. Compared to conventional ampicillin, the hybrid treatment of CGD was significantly more cost-effective, increased productivity, and had minor accumulation. The acquired results may also be applied to further plant disease treatment.

Background and Aim: Feline immunodeficiency virus (FIV) causes AIDS-like symptoms in domestic and wild cats. Treatment of infected cats has been performed using human anti-HIV drugs, which showed some limitations. This study aimed to determine the anti-FIV potential of some mushrooms. Materials and Methods: A total of 17 medicinal and edible mushrooms were screened to find their inhibitory effect against FIV reverse transcriptase (FIV-RT). Three solvents, water, ethanol, and hexane, were used to prepare crude mushroom extracts. Fluorescence spectroscopy was used to perform relative inhibition and 50% inhibitory concentrations (IC50) studies. Results: The ethanol extract from dried fruiting bodies of Inonotus obliquus showed the strongest inhibition with an IC50 value of 0.80±0.16 μg/mL. The hexane extract from dried mycelium of I. obliquus and ethanol and water extracts from fresh fruit bodies of Phellinus igniarius also exhibited strong activities with the IC50 values of 1.22±0.20, 4.33±0.39, and 6.24±1.42 μg/mL, respectively. The ethanol extract from fresh fruiting bodies of Cordyceps sinensis, hexane extracts from dried mycelium of I. obliquus, ethanol extracts of Ganoderma lucidum, hexane extracts of fresh fruiting bodies of Morchella esculenta, and fresh fruiting bodies of C. sinensis showed moderate anti-FIV-RT activities with IC50 values of 29.73±12.39, 49.97±11.86, 65.37±14.14, 77.59±8.31, and 81.41±17.10 μg/mL, respectively. These mushroom extracts show anti-FIV potential. Conclusion: The extracts from I. obliquus, P. igniarius, C. sinensis, and M. esculenta showed potential anti-FIV activity.

Kerra™, a Thai traditional herbal medicine derived from the “Tak-Ka-Si-La Scripture” and composed of nine medicinal plants, has demonstrated potential antiviral properties against HIV. This study investigated the inhibitory effects of Kerra™ on HIV-1 reverse transcriptase (RT) and its ability to prevent pseudo-HIV viral infection in HEK293 cells. The results showed that Kerra™ extract achieved a 95.73 ± 4.24% relative inhibition of HIV-1 RT, with an IC₅₀ value of 42.66 ± 8.74 µg/mL. Docking studies revealed that key phytochemicals in Kerra™, such as oleamide, formononetin, and biochanin A, interact with several residues in the RT non-nucleoside binding pocket, contributing to their inhibitory effects. Furthermore, Kerra™ was able to reduce pseudo-HIV infection in HEK293 cells at a concentration of 10 µg/mL, suggesting its potential as a supplementary treatment for HIV.

Background and Objectives: Cervical cancer is one of the most common types of frequently found cancers in Thailand. One of the causative agents is the infection of the high-risk human papillomavirus (HPV) type 16 and 18. Traditional medicines are rich sources of bioactive compounds which are a valuable source for the development of novel cancer therapies. In this study, the therapeutic effects of 3 traditional medicines, Kerra^TM, KS^TM, and Minoza^TM, were studied on HeLa and CaSki cells. Materials and Methods: The effects of Kerra^TM, KS^TM, and Minoza^TM on cancer cells were evaluated through cytotoxicity and cell death assays. The infection assay using HPV-16 pseudovirus was also carried out. Results: All traditional medicines efficiently suppressed cell growths of HeLa and CaSki, with Kerra^TM being the most potent anticancer agent followed by KS^TM and Minoza^TM. Kerra^TM at 158 µg/mL and 261 µg/mL significantly increases the percentage inhibition of the HPV-16 pseudovirus infection in a pre-attachment step in a dose-dependent manner, while KS^TM at 261 µg/mL efficiently inhibited viral infection in both pre-attachment and adsorption steps. However, Kerra^TM, KS^TM, and Minoza^TM at subtoxic concentrations could not reduce the viral E6 mRNA expressions of HPV-16 and HPV-18. Cell death assay by acridine orange/ethidium bromide showed that Kerra^TM increased population of dead cells in dose-dependent manner in both CaSki and HeLa. The percentage of secondary necrosis in Kerra^TM-treated CaSki was higher than that of HeLa cells, while the percentage of late apoptotic cells in HeLa was higher than that of CaSki, indicating that HeLa was more susceptible to Kerra^TM than CaSki. For KS^TM and Minoza^TM, these extracts at 250 µg/mL promoted autophagy over cell death. At 500 µg/mL, the percentage of dead cells in Kerra^TM was higher than that of KS^TM and Minoza^TM. Conclusions: Kerra^TM is a potent traditional medicine for promoting cancer cell death. Kerra^TM is possibly useful in the prevention and treatment of cervical cancer. Further investigation will be carried out to gain a better understanding of the biochemical mechanism and the pharmacological activity underlying this effect.

Rattanabunyong S, et al. J Vet Sci. 2023 Aug;24:e67. https://doi.org/10.4142/jvs.22326